Skip to main content

CYTOKINETICS INC

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

CYTK$56.18+1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(In thousands) (Unaudited)

Six Months Ended
June 30, 2026June 30, 2025
Cash flows from operating activities:
Net loss$(404,793)$(295,746)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense on liabilities related to revenue participation right purchase agreements38,99327,311
Stock-based compensation expense66,10551,084
Non-cash lease expense3,2102,566
Depreciation of property and equipment7,0094,585
Change in fair value of derivative liabilities(400)(2,600)
Change in fair value of liabilities related to RPI Transactions(800)10,700
Realized gain on investment, net(121)(16)
Interest receivable and amortization on investments(6,226)(10,206)
Non-cash interest expense related to debt17,1868,783
Changes in operating assets and liabilities:
Accounts receivable(6,668)8,240
Prepaid and other assets(2,786)(5,013)
Inventories(5,823)—
Accounts payable1,549(3,626)
Deferred revenue41(51,026)
Accrued and other liabilities(966)(382)
Operating lease liabilities(3,742)(4,466)
Other non-current liabilities(7,065)(41)
Net cash used in operating activities(305,297)(259,853)
Cash flows from investing activities:
Purchases of investments(833,781)(382,071)
Investment in non-marketable equity security—(5,000)
Maturities of investments482,539549,725
Sales of investments—5,992
Purchases of property and equipment(10,264)(9,809)
Net cash (used in) provided by investing activities(361,506)158,837
Cash flows from financing activities:
Repayment of finance lease liabilities—(204)
Repayment of term loans(6,329)(5,378)
Payments of royalty obligations(214)—
Proceeds from RPI Transactions—75,000
Proceeds from issuance of common stock related to public offering, net of issuance costs760,149—
Proceeds from issuance of common stock under equity incentive and stock purchase plans49,34814,396
Taxes paid related to net share settlement of equity awards(2,327)(527)
Net cash provided by financing activities800,62783,287
Effect of exchange rate changes on cash(1,078)(952)
Net increase (decrease) in cash, cash equivalents, and restricted cash132,746(18,681)
Cash, cash equivalents, and restricted cash, beginning of period125,63295,232
Cash, cash equivalents, and restricted cash, end of period$258,378$76,551
Supplemental cash flow disclosures:
Cash paid for interest$12,194$10,253
Non-cash investing and financing activities:
Right-of-use assets recognized in exchange for operating lease obligations$170$3,501
Amounts unpaid for purchases of property and equipment$113$2,830
Conversion of 2026 Notes$21,067$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.